Whether you’re looking to stock up on wellness essentials, update your jewelry collection, or perfect your home setup, Black Friday 2025 is bringing deals worth getting excited about. The biggest ...
-- Anticipated topline data readouts on track for ongoing Phase 3 studies of MM120 Orally Disintegrating Tablet (ODT) in GAD: Voyage (1H 2026) and Panorama (2H 2026)-- --Anticipated topline data ...
The Apache Software Foundation disputes claims that its OpenOffice project suffered an Akira ransomware attack, after the threat actors claimed to have stolen 23 GB of corporate documents. Apache ...
Pfizer Inc ((PFE)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
Early research on proton craniospinal irradiation (pCSI) reported potential benefits for patients with LMD. Notably, the final analysis of a randomized phase 2 trial by Yang et al of 63 patients with ...
The best label maker is a boost to your storage and organization efforts, whether that’s sorting a spice rack or slapping your kid’s name on their back-to-school stuff. It makes closets and drawers ...
Nurtec ODT (rimegepant) is a prescription drug that’s used to treat and help prevent migraine. Nurtec ODT comes as an orally disintegrating tablet. Nurtec ODT is a brand-name medication. It contains ...
Abstract: Estimating blood flow speed is essential in many medical and physiological applications, yet it is extremely challenging due to complex vascular structure and flow dynamics, particularly for ...
Mind Medicine Inc (NASDAQ:MNMD) is on track with enrollment for its three pivotal phase 3 trials for MM-120 ODT, targeting generalized anxiety disorder (GAD) and major depressive disorder (MDD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback